Shorla Oncology has been chosen as a finalist for the Reuters Global Pharma Awards in the Most Valuable Breakthrough/Discovery category. We are grateful to be recognized amongst such an incredible list of life science companies.
Read more at: https://www.reutersevents.com/events/awards/
